bioRxiv Science⌕ Search

Biology subjects

Firmani, S.

Publications and source records attributed to Firmani, S..

2 recordsLinked to original sources

RIBEX: Predicting and Explaining RNA Binding Across Structured and Intrinsically Disordered Regions (IDR)-rich Proteins

MotivationRNA-binding proteins (RBPs) regulate post-transcriptional processes, yet many remain undiscovered because RNA-binding activity often occurs outside canonical RNA-binding domains (RBDs), including within intrinsically disordered regions (IDRs) or through protein complexes. Computational methods can help identify novel RBPs, but approaches relying solely on sequence-derived features or ignoring the cellular interaction context are limited in capturing the complexity of RNA-binding behavior. To date, no framework rigorously integrates both sequence information and protein interaction context for RBP prediction. ResultsWe introduce RIBEX, a multimodal framework that combines protein language model (pLM) embeddings with protein interactome topology to improve RBP prediction and interpretation. Specifically, we integrate sequence representations with graph-derived positional encodings (PE) from the human STRING protein-protein interaction (PPI) network. PE are computed using Personalized PageRank, reduced with principal component analysis, and fused with pooled sequence embeddings through FiLM conditioning, while Low-Rank Adaptation (LoRA) enables parameter-efficient task adaptation. Across both an annotation-based benchmark and experimental RNA Interactome Capture (RIC) dataset, PE consistently improves predictive performance, indicating that interactome topology provides complementary information beyond sequence features. LoRA adaptation of ESM2-650M further yields larger gains than simply scaling frozen backbone size. RIBEX outperforms state-of-the-art methods such as RBP-TSTL and HydRA, particularly on challenging subsets including proteins lacking canonical RBDs and those enriched in IDRs. For interpretability, we combine sequence-level computational alanine scanning with network-level positional-encoding ablation and inverse-PCA mapping, recovering known RNA-binding domains, IDR-associated contributions, and functional interactome communities linked to RBP predictions.

bioinformatics↗

Path-based reasoning in biomedical knowledge graphs

Understanding complex interactions in biomedical networks is crucial for advancements in biomedicine, but traditional link prediction (LP) methods are limited in capturing this complexity. Representation-based learning techniques improve prediction accuracy by mapping nodes to low-dimensional embeddings, yet they often struggle with interpretability and scalability. We present BioPathNet, a novel graph neural network framework based on the Neural Bellman-Ford Network (NBFNet), addressing these limitations through path-based reasoning for LP in biomedical knowledge graphs. Unlike node-embedding frameworks, BioPathNet learns representations between node pairs by considering all relations along paths, enhancing prediction accuracy and interpretability. This allows visualization of influential paths and facilitates biological validation. BioPathNet leverages a background regulatory graph (BRG) for enhanced message passing and uses stringent negative sampling to improve precision. In evaluations across various LP tasks, such as gene function annotation, drug-disease indication, synthetic lethality, and lncRNA-mRNA interaction prediction, BioPathNet consistently outperformed shallow node embedding methods, relational graph neural networks and task-specific state-of-the-art methods, demonstrating robust performance and versatility. Our study predicts novel drug indications for diseases like acute lymphoblastic leukemia (ALL) and Alzheimers, validated by medical experts and clinical trials. We also identified new synthetic lethality gene pairs and regulatory interactions involving lncRNAs and target genes, confirmed through literature reviews. BioPathNets interpretability will enable researchers to trace prediction paths and gain molecular insights, making it a valuable tool for drug discovery, personalized medicine and biology in general.

bioinformatics↗